Role of Brachytherapy in the Postoperative Management of Endometrial Cancer: Decision-Making Analysis among Experienced European Radiation Oncologists

Glatzer, Markus; Tanderup, Kari; Rovirosa, Angeles; Fokdal, Lars; Ordeanu, Claudia; Tagliaferri, Luca; Chargari, Cyrus; Strnad, Vratislav; Dimopoulos, Johannes Athanasios; Šegedin, Barbara; Cooper, Rachel; Nakken, Esten Søndrol; Petric, Primoz; van der Steen-Banasik, Elzbieta; Lössl, Kristina; Jürgenliemk-Schulz, Ina M; Niehoff, Peter; Hermansson, Ruth S; Nout, Remi A; Putora, Paul Martin

doi:10.3390/cancers14040906

Citations

Citation copied

Glatzer, M., Tanderup, K., Rovirosa, A., Fokdal, L., Ordeanu, C., Tagliaferri, L., Chargari, C., Strnad, V., Dimopoulos, J. A., Šegedin, B., Cooper, R., Nakken, E. S., Petric, P., van der Steen-Banasik, E., Lössl, K., Jürgenliemk-Schulz, I. M., Niehoff, P., Hermansson, R. S., Nout, R. A., … Tselis, N. (2022). Role of Brachytherapy in the Postoperative Management of Endometrial Cancer: Decision-Making Analysis among Experienced European Radiation Oncologists. Cancers, 14(4), 906. https://doi.org/10.3390/cancers14040906

Abstract

BACKGROUND

There are various society-specific guidelines addressing adjuvant brachytherapy (BT) after surgery for endometrial cancer (EC). However, these recommendations are not uniform. Against this background, clinicians need to make decisions despite gaps between best scientific evidence and clinical practice. We explored factors influencing decision-making for adjuvant BT in clinical routine among experienced European radiation oncologists in the field of gynaecological radiotherapy (RT). We also investigated the dose and techniq